Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collagenase Clostridium Histolytic is a Common Treatment of MCP and PIP Joint Contractures in Dupuytren Disease. A 1 to 4 Year Followup Study of 198 Joints

NCT03331926 is registered in ClinicalTrials.gov with Jeppe Lange as lead sponsor.

NCT NCT03331926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03331926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collagenase Clostridium Histolytic is a Common Treatment of MCP and PIP Joint Contractures in Dupuytren Disease. A 1 to 4 Year Followup Study of 198 Joints
Lead sponsor
Jeppe Lange
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
December 31, 2019
Enrollment
199 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dupuytren contracture